Tianjin Medical Journal ›› 2024, Vol. 52 ›› Issue (3): 237-244.doi: 10.11958/20231013
• Cell and Molecular Biology • Previous Articles Next Articles
LI Wei1(), CHEN Liang1, LYU Changying2,△(
)
Received:
2023-07-27
Revised:
2023-09-18
Published:
2024-03-15
Online:
2024-03-13
Contact:
△E-mail: LI Wei, CHEN Liang, LYU Changying. circ_HIPK3 regulates function and morphology of Aβ induced hippocampal neurons by targeting miR-381-3p/ZNF217 axis[J]. Tianjin Medical Journal, 2024, 52(3): 237-244.
CLC Number:
基因名称 | 引物序列(5′→3′) | 产物大 小/bp |
---|---|---|
circ_HIPK3 | 上游:ATGGCCTCACAAGTCTTGGTC | 189 |
下游:GCACTACCTTTCGTGGAGGAT | ||
ZNF217 | 上游:TCCAAATGTGCTGACTGTTC | 201 |
下游:CTCTTTTGTGCCATGCTGTT | ||
GAPDH | 上游:AATCCCATCACCATCTTCCAG | 128 |
下游:CCTTCTCCATGGTGGTGAAGAC | ||
miR-381-3p | 上游:TAATCTGACTATACAAGGGCAAGCT | 87 |
下游:TATGGTTGTTCTGCTCTCTGTCTC | ||
U6 | 上游:CTCGCTTCGGCAGCACA | 96 |
下游:AACGCTTCACGAATTTGCGT |
Tab.1 Primer sequence
基因名称 | 引物序列(5′→3′) | 产物大 小/bp |
---|---|---|
circ_HIPK3 | 上游:ATGGCCTCACAAGTCTTGGTC | 189 |
下游:GCACTACCTTTCGTGGAGGAT | ||
ZNF217 | 上游:TCCAAATGTGCTGACTGTTC | 201 |
下游:CTCTTTTGTGCCATGCTGTT | ||
GAPDH | 上游:AATCCCATCACCATCTTCCAG | 128 |
下游:CCTTCTCCATGGTGGTGAAGAC | ||
miR-381-3p | 上游:TAATCTGACTATACAAGGGCAAGCT | 87 |
下游:TATGGTTGTTCTGCTCTCTGTCTC | ||
U6 | 上游:CTCGCTTCGGCAGCACA | 96 |
下游:AACGCTTCACGAATTTGCGT |
组别 | circ_HIPK3 | miR-381-3p | ZNF217 | |
---|---|---|---|---|
mRNA | 蛋白 | |||
对照组 | 1.01±0.14 | 1.00±0.16 | 1.02±0.12 | 0.32±0.04 |
Aβ组 | 2.97±0.42a | 0.42±0.07a | 2.54±0.31a | 0.78±0.09a |
si NC1组 | 2.99±0.42 | 0.43±0.07 | 2.52±0.31 | 0.76±0.09 |
si HIPK3组 | 1.62±0.23b | 0.62±0.10b | 2.02±0.25b | 0.41±0.05b |
si HIPK3+inhibitor NC组 | 1.63±0.23 | 0.63±0.10 | 2.01±0.25 | 0.42±0.05 |
si HIPK3+miR-381-3p inhibitor组 | 2.05±0.29c | 0.51±0.08c | 2.16±0.27c | 0.45±0.05c |
si HIPK3+miR-381-3p inhibitor+si NC2组 | 2.04±0.29 | 0.51±0.08 | 2.17±0.27 | 0.46±0.05 |
si HIPK3+miR-381-3p inhibitor+si ZNF217组 | 2.03±0.28 | 0.59±0.09 | 1.95±0.24d | 0.40±0.05d |
F | 30.018* | 21.379* | 20.006* | 46.846* |
Tab.2 The expression levels of circ_HIPK3, miR-381-3p and ZNF217 between eight groups of hippocampal neurons
组别 | circ_HIPK3 | miR-381-3p | ZNF217 | |
---|---|---|---|---|
mRNA | 蛋白 | |||
对照组 | 1.01±0.14 | 1.00±0.16 | 1.02±0.12 | 0.32±0.04 |
Aβ组 | 2.97±0.42a | 0.42±0.07a | 2.54±0.31a | 0.78±0.09a |
si NC1组 | 2.99±0.42 | 0.43±0.07 | 2.52±0.31 | 0.76±0.09 |
si HIPK3组 | 1.62±0.23b | 0.62±0.10b | 2.02±0.25b | 0.41±0.05b |
si HIPK3+inhibitor NC组 | 1.63±0.23 | 0.63±0.10 | 2.01±0.25 | 0.42±0.05 |
si HIPK3+miR-381-3p inhibitor组 | 2.05±0.29c | 0.51±0.08c | 2.16±0.27c | 0.45±0.05c |
si HIPK3+miR-381-3p inhibitor+si NC2组 | 2.04±0.29 | 0.51±0.08 | 2.17±0.27 | 0.46±0.05 |
si HIPK3+miR-381-3p inhibitor+si ZNF217组 | 2.03±0.28 | 0.59±0.09 | 1.95±0.24d | 0.40±0.05d |
F | 30.018* | 21.379* | 20.006* | 46.846* |
组别 | 细胞存活率/% | 细胞凋亡率/% | Ca2+荧光强度 |
---|---|---|---|
对照组 | 100.00±14.28 | 3.24±0.46 | 30.22±4.31 |
Aβ组 | 47.26±6.75a | 25.66±3.66a | 76.17±10.88a |
si NC2组 | 46.57±6.66 | 25.17±3.59 | 75.89±10.84 |
si HIPK3组 | 79.81±11.40b | 13.22±1.88b | 42.66±6.09b |
si HIPK3+inhibitor NC组 | 78.66±11.23 | 13.50±1.92 | 42.57±6.09 |
si HIPK3+miR-381-3p inhibitor组 | 62.55±8.93c | 19.86±2.83c | 61.98±8.85c |
si HIPK3+miR-381-3p inhibitor+si NC2组 | 62.79±8.97 | 19.79±2.83 | 62.05±8.86 |
si HIPK3+miR-381-3p inhibitor+si ZNF217组 | 71.28±10.18d | 14.55±2.08d | 50.42±7.21d |
F | 18.801* | 54.344* | 24.552* |
Tab.3 Comparison of survival rate, apoptosis rate and Ca2+ fluorescence intensity between eight groups of hippocampal neurons
组别 | 细胞存活率/% | 细胞凋亡率/% | Ca2+荧光强度 |
---|---|---|---|
对照组 | 100.00±14.28 | 3.24±0.46 | 30.22±4.31 |
Aβ组 | 47.26±6.75a | 25.66±3.66a | 76.17±10.88a |
si NC2组 | 46.57±6.66 | 25.17±3.59 | 75.89±10.84 |
si HIPK3组 | 79.81±11.40b | 13.22±1.88b | 42.66±6.09b |
si HIPK3+inhibitor NC组 | 78.66±11.23 | 13.50±1.92 | 42.57±6.09 |
si HIPK3+miR-381-3p inhibitor组 | 62.55±8.93c | 19.86±2.83c | 61.98±8.85c |
si HIPK3+miR-381-3p inhibitor+si NC2组 | 62.79±8.97 | 19.79±2.83 | 62.05±8.86 |
si HIPK3+miR-381-3p inhibitor+si ZNF217组 | 71.28±10.18d | 14.55±2.08d | 50.42±7.21d |
F | 18.801* | 54.344* | 24.552* |
组别 | P-Tau | Bcl-2 | Bax | Caspase-3 |
---|---|---|---|---|
对照组 | 0.84±0.12 | 0.76±0.12 | 0.22±0.03 | 0.36±0.05 |
Aβ组 | 1.96±0.28a | 0.31±0.05a | 0.83±0.11a | 0.75±0.10a |
si NC2组 | 1.97±0.28 | 0.30±0.05 | 0.82±0.11 | 0.76±0.10 |
si HIPK3组 | 1.12±0.16b | 0.55±0.09b | 0.41±0.05b | 0.43±0.06b |
si HIPK3+inhibitor NC组 | 1.13±0.16 | 0.54±0.09 | 0.40±0.05 | 0.44±0.06 |
si HIPK3+miR-381-3p inhibitor组 | 1.45±0.20c | 0.37±0.06c | 0.68±0.09c | 0.61±0.08c |
si HIPK3+miR-381-3p inhibitor+si NC2组 | 1.46±0.21 | 0.36±0.06 | 0.67±0.09 | 0.62±0.08 |
si HIPK3+miR-381-3p inhibitor+si ZNF217组 | 1.02±0.10d | 0.54±0.07d | 0.45±0.06d | 0.45±0.07d |
F | 26.997* | 25.414* | 47.107* | 23.892* |
Tab.4 Comparison of P-Tau, Bcl-2, Bax and Caspase-3 protein expression between eight groups of hippocampal neurons
组别 | P-Tau | Bcl-2 | Bax | Caspase-3 |
---|---|---|---|---|
对照组 | 0.84±0.12 | 0.76±0.12 | 0.22±0.03 | 0.36±0.05 |
Aβ组 | 1.96±0.28a | 0.31±0.05a | 0.83±0.11a | 0.75±0.10a |
si NC2组 | 1.97±0.28 | 0.30±0.05 | 0.82±0.11 | 0.76±0.10 |
si HIPK3组 | 1.12±0.16b | 0.55±0.09b | 0.41±0.05b | 0.43±0.06b |
si HIPK3+inhibitor NC组 | 1.13±0.16 | 0.54±0.09 | 0.40±0.05 | 0.44±0.06 |
si HIPK3+miR-381-3p inhibitor组 | 1.45±0.20c | 0.37±0.06c | 0.68±0.09c | 0.61±0.08c |
si HIPK3+miR-381-3p inhibitor+si NC2组 | 1.46±0.21 | 0.36±0.06 | 0.67±0.09 | 0.62±0.08 |
si HIPK3+miR-381-3p inhibitor+si ZNF217组 | 1.02±0.10d | 0.54±0.07d | 0.45±0.06d | 0.45±0.07d |
F | 26.997* | 25.414* | 47.107* | 23.892* |
组别 | WT HIPK3 | MUT HIPK3 | WT ZNF217 | MUT ZNF217 |
---|---|---|---|---|
mimics NC组 | 1.03±0.12 | 1.02±0.11 | 1.11±0.11 | 1.12±0.10 |
miR-381-3p mimics组 | 0.26±0.04a | 1.00±0.11 | 0.29±0.02a | 1.14±0.10 |
t | 14.911* | 0.315 | 17.965* | 0.346 |
Tab.5 Targeting relationship between miR-381-3p and circ_HIPK3 and ZNF217
组别 | WT HIPK3 | MUT HIPK3 | WT ZNF217 | MUT ZNF217 |
---|---|---|---|---|
mimics NC组 | 1.03±0.12 | 1.02±0.11 | 1.11±0.11 | 1.12±0.10 |
miR-381-3p mimics组 | 0.26±0.04a | 1.00±0.11 | 0.29±0.02a | 1.14±0.10 |
t | 14.911* | 0.315 | 17.965* | 0.346 |
[1] | 刘书雨, 张巍. 阿尔茨海默病相关心脏结构和功能损害[J]. 中国现代神经疾病杂志, 2023, 23(4):282-286. |
LIU S Y, ZHANG W. Alzheimer's disease related heart structural and functional damage[J]. Chinese Journal of Contemporary Neurology and Neurosurgery, 2023, 23(4):282-286. doi: 10.3969/j.issn.1672-6731.2023.04.003. | |
[2] | ERATNE D, LOI S M, FARRAND S, et al. Alzheimer's disease:clinical update on epidemiology,pathophysiology and diagnosis[J]. Australas Psychiaty, 2018, 26(4):347-357. doi:1177.1039856218762308/2018. |
[3] | PINHEIRO L, FAUSTINO C. Therapeutic strategies targeting amyloid-β in Alzheimer's disease[J]. Curr Alzheimer Res, 2019, 16(5):418-452. doi:10.2174/1567205016666190321163438. |
[4] | 夏立军, 衣服新, 翟旭, 等. 环状RNA同源域相互作用蛋白激酶3(circHIPK3)通过吸附miR-124-3p促进神经胶质瘤细胞增殖及转移[J]. 细胞与分子免疫学杂志, 2020, 36(7):609-615. |
XIA L J, YI F X, ZHAI X, et al. circHIPK3 promotes the proliferation and metastasis of glioma cells by adsorption of miR-124-3p[J]. Journal of Cellular and Molecular Immunology, 2020, 36(7):609-615. doi:10.13423/j.cnki.cjcmi.009032. | |
[5] | LIU Y, AO S, ZHANG H, et al. Circ_HIPK3 alleviates CoCl2-induced apoptotic injury in neuronal cells by depending on the regulation of the miR-222-3p/DUSP19 axis[J]. Biochem Biophys Res Commun, 2021, 553(1):126-133. doi:10.1016/j.bbrc.2021.03.070. |
[6] | ZHANG M, LIU Y, TENG P, et al. Differential expression of miR-381-3p in Alzheimer's disease patients and its role in Beta-amyloid-induced neurotoxicity and inflammation[J]. Neuroimminomodulation, 2022, 29(3):211-219. doi:10.1159/000519780. |
[7] | 惠娟, 王娜娜, 张毓洪, 等. ZNF224基因与阿尔茨海默病风险关联的研究[J]. 中国老年保健医学, 2014, 12(2):5-9. |
HUI J, WANG N N, ZHANG Y H, et al. Association between ZNF224 gene and risk of Alzheimer's disease[J]. Chinese Journal of Geriatric Medicine, 2014, 12(2):5-9. doi:10.3969/j.issn.1672-4860.2014.02.001. | |
[8] | WANG J, ZHOU T, WANG T, et al. Suppression of lncRNA-ATB prevents amyloid-β-induced neurotoxicity in PC12 cells via regulating miR-200/ZNF217 axis[J]. Biomed Pharmacother, 2018, 108:707-715. doi:10.1016/j.biopha.2018.08.155. |
[9] | 赵美英, 史文倩, 汪桂青. 长链非编码RNA生长抑制特异因子5调控微小RNA-137对Aβ诱导大鼠海马神经元损伤的影响[J]. 中国比较医学杂志 2021, 31(9):64-71. |
ZHAO M Y, SHI W Q, WANG G Q. Effect of long non-coding RNA growth inhibition factor 5 on MicrornA-137 induced hippocampal neuron injury in rats[J]. Chinese Journal of Comparative Medicine, 2021, 31(9):64-71. doi:10.3969/j.issn.1671-7856.2021.09.010. | |
[10] | 刘镇, 郝凯敏, 祁文秀. HDAC6通过调控HSP90影响Aβ诱导的大鼠海马神经元细胞功能和形态的研究[J]. 中国细胞生物学学报, 2020, 42(4):8. |
LIU Z, HAO K M, QI W X. Effect of HDAC6 on the function and morphology of rat hippocampal neurons induced by Aβ through regulation of HSP90[J]. Chinese Journal of Cell Biology, 2020, 42(4):8. doi:10.11844/cjcb.2020.04.0001. | |
[11] | RUAN Z, PATHAK D, KALAVAI S, et al. Alzheimer's disease brain-derived extracellular vesicles spread tau pathology in interneurons[J]. Brain, 2021, 144(1):288-309. doi:10.1093/brain/awaa376. |
[12] | 田芳, 王云, 肖哲, 等. 环状RNA CircHIPK3通过miR-379调控IGF1表达促进非小细胞肺癌细胞系NCI-H1299与NCI-H2170的细胞增殖[J]. 中国肺癌杂志, 2017, 20(7):459-467. |
TIAN F, WANG Y, XIAO Z, et al. CircHIPK3 promotes cell proliferation of non-small cell lung cancer cell lines NCI-H1299 and NCI-H2170 by regulating IGF1 expression through miR-379[J]. Chinese Journal of Lung Cancer, 2017, 20(7):459-467. doi:10.3779/j.issn.1009-3419.2017.07.04. | |
[13] | 徐宇飞, 曾俊杰, 邓翰林. circ-HIPK3通过调控miR-1207-5p促进结直肠癌细胞增殖和转移的作用机制[J]. 贵州医科大学学报, 2022, 47(7):852-857. |
XU Y F, ZENG J J, DENG H L. circ-HIPK3 promotes the proliferation and metastasis of colorectal cancer cells by regulating miR-1207-5p[J]. Journal of Guizhou Medical University, 2022, 47(7):852-857. doi:10.19367/j.cnki.2096-8388.2022.07.019. | |
[14] | ZHAO J, QI X, BAI J, et al. A circRNA derived from linear HIPK3 relieves the neuronal cell apoptosis in spinal cord injury via ceRNA pattern[J]. Biochem Biophys Res Commun, 2020, 528(2):359-367. doi:10.1016/j.bbrc.2020.02.108. |
[15] | FU Y, SUN X, LU B. HIPK3 modulates autophagy and HTT protein levels in neuronal and mouse models of Huntington disease[J]. Autophagy, 2018, 14(1):169-170. doi:10.1080/15548627.2017.1393130. |
[16] | FEDRIZZI L, CARAFOLI E. Ca2+ dysfunction in neurodegenerative disorders:Alzheimer's disease[J]. Biofactors, 2011, 37(3):189-196. doi:10.1002/biof.157. |
[17] | WU L, DU Q, WU C, et al. CircLPAR1/miR-212-3p/ZNF217 feedback loop promotes amyloid β-induced neuronal injury in Alzheimer's Disease[J]. Brain Res, 2021, 1770:147622. doi:10.1016/j.brainres.2021.147622. |
[18] | GAO Y, ZHANG N, LV C, et al. lncRNA SNHG1 knockdown alleviates amyloid-β-induced neuronal injury by regulating ZNF217 via sponging miR-361-3p in Alzheimer's disease[J]. J Alzheimers Dis, 2020, 77(1):85-98. doi:10.3233/JAD-191303. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||